Swiggy share price fell 7.4% after announcing a consolidated loss of ₹799.08 crore for Q3 2024, up from ₹574.38 crore last year.(Pixabay) Sriharsha Majety, the MD & Group CEO of Swiggy ...

(Reuters) -Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not ... the miss to issues in the supply chain. Lilly also said on the call that ...

“The minister will deliver a statement regarding the padi issue, specifically related to the padi floor price, on Feb 13,” he said at the weekly post-Cabinet press conference. On Jan ...

and said it saw "intact strong demand for obesity treatments" in the United States and elsewhere. The company said it expects U.S. growth of its diabetes and weight-loss drugs to be consistent ...

Robinson closed Wednesday's 138-107 loss to the Grizzlies with one point (1-2 FT) across three minutes. Robinson continues to be used sparingly by the Raptors, having played fewer than 15 minutes ...

Eli Lilly reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but saw lower realized prices. Demand in the U.S. has far outpaced supply ...

Novo CEO Lars Fruergaard Jorgensen sees Wegovy supply improving this year, and brushed off fears of the company falling behind Eli Lilly & Co. Details about its next-generation weight loss drugs ...

further risking downward pressure on oil over concerns of slowing economic growth and lower demand. The threat of tariffs has outweighed the risk of supply restrictions. On Friday, oil futures ...

Consumer price inflation in India is among the highest ... JSW Steel‘s Joint Managing Director and Group CFO Seshagiri Rao says demand-supply gap impacted domestic prices in the September ...